Detalhe da pesquisa
1.
Biomarker analysis from the phase 2b randomized placebo-controlled trial of riociguat in early diffuse cutaneous systemic sclerosis.
Rheumatology (Oxford)
; 2024 Mar 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38460548
2.
Clinical and genomic analysis of metastatic prostate cancer progression with a background of postoperative biochemical recurrence.
BJU Int
; 116(4): 556-67, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25762434
3.
Secreted protein, acidic and rich in cysteine-like 1 (SPARCL1) is down regulated in aggressive prostate cancers and is prognostic for poor clinical outcome.
Proc Natl Acad Sci U S A
; 109(37): 14977-82, 2012 Sep 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-22927397
4.
Validation of a genomic classifier that predicts metastasis following radical prostatectomy in an at risk patient population.
J Urol
; 190(6): 2047-53, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23770138
5.
Decentralized clinical trials and rare diseases: a Drug Information Association Innovative Design Scientific Working Group (DIA-IDSWG) perspective.
Orphanet J Rare Dis
; 18(1): 79, 2023 04 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37041605
6.
Innovations in Clinical Development in Rare Diseases of Children and Adults: Small Populations and/or Small Patients.
Paediatr Drugs
; 24(6): 657-669, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36241954
7.
Deep learning on resting electrocardiogram to identify impaired heart rate recovery.
Cardiovasc Digit Health J
; 3(4): 161-170, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36046430
8.
Cohort design and natural language processing to reduce bias in electronic health records research.
NPJ Digit Med
; 5(1): 47, 2022 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35396454
9.
A roadmap to using historical controls in clinical trials - by Drug Information Association Adaptive Design Scientific Working Group (DIA-ADSWG).
Orphanet J Rare Dis
; 15(1): 69, 2020 03 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32164754
10.
Increasing the efficiency of oncology basket trials using a Bayesian approach.
Contemp Clin Trials
; 63: 67-72, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28629993
11.
Utility of Risk Models in Decision Making After Radical Prostatectomy: Lessons from a Natural History Cohort of Intermediate- and High-Risk Men.
Eur Urol
; 69(3): 496-504, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25922274
12.
A comparison of five methods for selecting tagging single-nucleotide polymorphisms.
BMC Genet
; 6 Suppl 1: S71, 2005 Dec 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-16451685
13.
Combined value of validated clinical and genomic risk stratification tools for predicting prostate cancer mortality in a high-risk prostatectomy cohort.
Eur Urol
; 67(2): 326-33, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24998118
14.
Discovery and validation of novel expression signature for postcystectomy recurrence in high-risk bladder cancer.
J Natl Cancer Inst
; 106(11)2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25344601
15.
Genomic prostate cancer classifier predicts biochemical failure and metastases in patients after postoperative radiation therapy.
Int J Radiat Oncol Biol Phys
; 89(5): 1038-1046, 2014 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25035207
16.
The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer.
Nat Commun
; 5: 5383, 2014 Nov 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-25415230
17.
Impact of a genomic classifier of metastatic risk on postoperative treatment recommendations for prostate cancer patients: a report from the DECIDE study group.
Oncotarget
; 4(4): 600-9, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23592338
18.
Whole-transcriptome profiling of thyroid nodules identifies expression-based signatures for accurate thyroid cancer diagnosis.
J Clin Endocrinol Metab
; 98(10): 4072-9, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23928671
19.
Discovery and validation of a prostate cancer genomic classifier that predicts early metastasis following radical prostatectomy.
PLoS One
; 8(6): e66855, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23826159
20.
The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex.
Nat Genet
; 45(11): 1392-8, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24076601